# US 2011/0256066 A1 · Method for preparing engineered mg doped ferrite superparamagnetic nano particle exhibiting ac magnetic induction heating at high temperature and mg doped ferrite superparamagnetic nano particles engineered by the method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0256066 A1
- Document ID: US20110256066A1
- Status: Published application
- Kind: A1
- Application number: 13/141,844
- Filed: 2009-12-24
- Published: 2011-10-20
- Earliest claimed: 2008-12-24
- Assignees: Nuri Vista Co., Ltd.
- Inventors: Seong-Tae Bae; Kyung-Won Chung
- Web page: https://patentgrep.com/patent/US20110256066A1

## CPC

- A61K 41/0052: {Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy}
- A61K 49/183: {having a (super)(para)magnetic core coated or functionalised with an inorganic material or being composed of an inorganic material entrapping the MRI-active nucleus, e.g. silica core doped with a MRI-active nucleus}
- A61K 49/1863: {the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch}
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 27/02: Ophthalmic agents
- A61P 27/06: Antiglaucoma agents or miotics
- A61P 35/00: Antineoplastic agents
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- B82Y 25/00: Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- C01G 49/0036: {containing one alkaline earth metal, magnesium or lead}
- C01P 2002/72: by d-values or two theta-values, e.g. as X-ray diagram
- C01P 2004/04: obtained by TEM, STEM, STM or AFM
- C01P 2004/64: Nanometer sized, i.e. from 1-100 nanometer
- C01P 2006/42: Magnetic properties
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- C01G: COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F (metal hydrides {monoborane, diborane or addition complexes thereof} C01B6/00; salts of oxyacids of halogens C01B11/00; peroxides, salts or peroxyacids C01B15/00; thiosulfates, dithionites, polythionates C01B17/64; compounds containing selenium, or tellurium C01B19/00; binary compounds of nitrogen with metals C01B21/06; azides C01B21/08; {compounds containing nitrogen, other non-metals and metal C01B21/082}; metal amides C01B21/092; nitrites C01B21/50; {compounds of noble gases C01B23/0005}; phosphides C01B25/08; salts of oxyacids of phosphorus C01B25/16; carbides C01B32/90; compounds containing silicon C01B33/00; compounds containing boron C01B35/00; compounds having molecular sieve properties but not having base-exchange properties C01B37/00; compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites, C01B39/00; cyanides C01C3/08; salts of cyanamide C01C3/16; thiocyanates C01C3/20)
- C01P: INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS

## Abstract

The present invention relates to a method for preparing a ferrite superparamagnetic nano particle engineered by magnesium doping, and a technique for applying it to hyperthermia cancer cell treatment and the heat shock protein (HSP) self-defense mechanism.

## Claims

### Claim at position 1

-17. (canceled)

### Claim 18

A method of preparing processed super paramagnetic Mg-doped ferrite nanoparticles having a particle size of 10 nm or less by doping Mg into ferrite particles, comprising:
mixing a raw material comprising Fe (III) acetylacetonate, magnesium, and a solvent;
performing primary heat treatment to create nuclei of nanoparticles; and
performing secondary heat treatment to grow the nuclei to form nanoparticles, followed by washing, centrifugal separation, drying, and grinding of the nanoparticles.

### Claim 19 (depends on 18)

The method of claim 18, wherein the raw material optionally further comprises hexadecanediol in a molar concentration of 10 mmol or less per 20 ml of the solvent.

### Claim 20 (depends on 18)

The method of claim 18, wherein the raw material further comprises a surfactant.

### Claim 21 (depends on 20)

The method of claim 20, wherein the surfactant comprises oleic acid and oleylamine.

### Claim 22 (depends on 18)

The method of claim 18, wherein the solvent comprises phenyl ether or benzyl ether.

### Claim 23 (depends on 18)

The method of claim 18, wherein the primary heat treatment is performed at 200° C. and the secondary heat treatment is performed at a temperature of 296° C.

### Claim 24 (depends on 18)

Processed super paramagnetic Mg-doped ferrite nanoparticles prepared by the method of claim 18 and having a saturation magnetization of 40-70 emu/g.

### Claim 25 (depends on 24)

The super paramagnetic Mg-doped ferrite nanoparticles of claim 24, wherein the super paramagnetic Mg-doped ferrite nanoparticles have a self-heating temperature of 10-105° C.

### Claim 26 (depends on 18)

The method of claim 18, further comprising: coating the nanoparticles with tetraethyl orthosilicate (TEOS), chitosan and D-glucose dextran.

### Claim 27 (depends on 18)

The method of claim 18, wherein the processed super paramagnetic Mg-doped ferrite nanoparticles are MgFe2O4, MgZnFe2O4, or MgMnFe2O4.

### Claim 28 (depends on 19)

The method of claim 19, wherein the raw material further comprises a surfactant.
